Izotropic Corporation (OTCMKTS:IZOZF – Get Free Report) saw a large growth in short interest in October. As of October 15th, there was short interest totaling 92,598 shares, a growth of 440.2% from the September 30th total of 17,142 shares. Based on an average daily volume of 72,016 shares, the short-interest ratio is presently 1.3 days. Currently, 0.1% of the shares of the stock are sold short.
Izotropic Stock Down 2.1%
IZOZF opened at $0.10 on Tuesday. The firm’s 50-day simple moving average is $0.14 and its 200-day simple moving average is $0.17. Izotropic has a twelve month low of $0.10 and a twelve month high of $0.37.
Izotropic (OTCMKTS:IZOZF – Get Free Report) last announced its quarterly earnings results on Monday, September 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by ($0.02). Equities analysts expect that Izotropic will post 0.03 earnings per share for the current fiscal year.
Izotropic Company Profile
Izotropic Corporation is a medical technology company focused on developing dedicated breast computed tomography (CT) imaging systems. Its principal product is the IzoView breast CT system, designed to produce three-dimensional images of the breast without the compression typically used in conventional mammography.
The company’s technology is intended to support breast-cancer screening and diagnostic imaging by providing detailed volumetric images that may help clinicians evaluate breast tissue and abnormalities.
Further Reading
- Five stocks we like better than Izotropic
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Izotropic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Izotropic and related companies with MarketBeat.com's FREE daily email newsletter.
